Baudax Bio, Inc. – NASDAQ:BXRX
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 3 days
Baudax Bio stock price monthly change
-7.41%
month
Baudax Bio stock price quarterly change
-85.71%
quarter
Baudax Bio stock price yearly change
-99.11%
year
Baudax Bio key metrics
Market Cap | N/A |
Enterprise value | 3.05M |
P/E | -0.01 |
EV/Sales | 2.40 |
EV/EBITDA | -0.05 |
Price/Sales | 0.94 |
Price/Book | -0.04 |
PEG ratio | N/A |
EPS | -2.54 |
Revenue | N/A |
EBITDA | -14.17M |
Income | -7.15M |
Revenue Q/Q | -100% |
Revenue Y/Y | -76.02% |
Profit margin | -4629.53% |
Oper. margin | -2814.33% |
Gross margin | -451.89% |
EBIT margin | -2814.33% |
EBITDA margin | N/A |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeBaudax Bio stock price history
Baudax Bio stock forecast
Baudax Bio financial statements
| Dec 2022 | 310K | -9.24M | -2983.55% |
|---|---|---|---|
| Mar 2023 | -14K | 11.40M | -81457.14% |
| Jun 2023 | 30K | -7.37M | -24583.33% |
| Sep 2023 | 0 | -1.93M |
| 2025 | 5.07M | -23.53M | -463.67% |
|---|
Analysts Price target
Financials & Ratios estimates
| Dec 2022 | 10032000 | 34.27M | 341.65% |
|---|---|---|---|
| Mar 2023 | 7065000 | 14.37M | 203.51% |
| Jun 2023 | 21316000 | 31.99M | 150.1% |
| Sep 2023 | 20583000 | 30.82M | 149.74% |
| Dec 2022 | -3.78M | 40K | 3.39M |
|---|---|---|---|
| Mar 2023 | -4.66M | 0 | 3.20M |
| Jun 2023 | -3.44M | 142K | 917K |
| Sep 2023 | -2.41M | -21K | 1.38M |
Baudax Bio alternative data
| Aug 2023 | 9 |
|---|---|
| Sep 2023 | 9 |
| Oct 2023 | 9 |
| Nov 2023 | 9 |
| Dec 2023 | 9 |
| Jan 2024 | 9 |
| Feb 2024 | 9 |
| Mar 2024 | 9 |
| Apr 2024 | 9 |
| May 2024 | 9 |
| Jun 2024 | 9 |
| Jul 2024 | 9 |
Baudax Bio other data
1.49%
-6.28%
of BXRX is owned by hedge funds
4.94K
-18.05K
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Dec 2022 | 1200 | 0 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Purchase | HENWOOD GERALDINE officer: Presiden.. | Common Stock | 1,200 | $2.55 | $3,058 | ||
Purchase | HENWOOD GERALDINE director, officer.. | Common Stock | 8,200 | $0.59 | $4,797 | ||
Purchase | CHURCHILL WINSTON J director | Common Stock | 100,000 | $0.63 | $62,900 | ||
Purchase | CASTEN RICHARD S | Common Stock | 50,000 | $0.51 | $25,500 | ||
Purchase | CHURCHILL WINSTON J director | Common Stock | 25,000 | $0.78 | $19,525 | ||
Purchase | CASTEN RICHARD S | Common Stock | 25,000 | $0.79 | $19,750 | ||
Purchase | BASKIES ARNOLD M director | Common Stock | 10,000 | $0.82 | $8,200 | ||
Purchase | HENWOOD GERALDINE director, officer.. | Common Stock | 6,000 | $0.83 | $4,992 | ||
Purchase | CASTEN RICHARD S | Common Stock | 25,000 | N/A | N/A | ||
Purchase | ALTOMARI ALFRED director | Common Stock | 5,000 | $1.06 | $5,300 |
| Patent |
|---|
Application Filling date: 7 Nov 2019 Issue date: 13 Jan 2022 |
Application Filling date: 23 Oct 2019 Issue date: 16 Dec 2021 |
Application Filling date: 5 Jun 2020 Issue date: 22 Apr 2021 |
Application Filling date: 8 Mar 2019 Issue date: 8 Apr 2021 |
Grant Filling date: 8 Mar 2019 Issue date: 5 Jan 2021 |
Grant Filling date: 25 Aug 2019 Issue date: 14 Jul 2020 |
Grant Filling date: 12 Sep 2017 Issue date: 16 Jun 2020 |
| Quarter | Transcript |
|---|---|
| Q1 2022 7 May 2022 | Q1 2022 Earnings Call Transcript |
| Q2 2021 8 Aug 2021 | Q2 2021 Earnings Call Transcript |
| Q1 2021 5 May 2021 | Q1 2021 Earnings Call Transcript |
| Q4 2020 16 Feb 2021 | Q4 2020 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
| Dr. Geraldine A. Henwood (1952) Pres, Chief Executive Officer & Director | $441,060 |
-
When is Baudax Bio's next earnings date?
Unfortunately, Baudax Bio's (BXRX) next earnings date is currently unknown.
-
Does Baudax Bio pay dividends?
No, Baudax Bio does not pay dividends.
-
What is Baudax Bio's stock symbol?
Baudax Bio, Inc. is traded on the NASDAQ under the ticker symbol "BXRX".
-
What is Baudax Bio's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Baudax Bio?
Shares of Baudax Bio can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Baudax Bio's key executives?
Baudax Bio's management team includes the following people:
- Dr. Geraldine A. Henwood Pres, Chief Executive Officer & Director(age: 73, pay: $441,060)
-
How many employees does Baudax Bio have?
As Jul 2024, Baudax Bio employs 9 workers.
-
When Baudax Bio went public?
Baudax Bio, Inc. is publicly traded company for more then 5 years since IPO on 14 Nov 2019.
-
What is Baudax Bio's official website?
The official website for Baudax Bio is baudaxbio.com.
-
Where are Baudax Bio's headquarters?
Baudax Bio is headquartered at 490 Lapp Road, Malvern, PA.
-
How can i contact Baudax Bio?
Baudax Bio's mailing address is 490 Lapp Road, Malvern, PA and company can be reached via phone at +48 43952440.
Baudax Bio company profile:
Baudax Bio, Inc.
baudaxbio.comExchange:
NASDAQ
Full time employees:
9
Industry:
Biotechnology
Sector:
Healthcare
Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care settings. The company offers ANJESO (meloxicam) injection for the management of moderate to severe pain, alone or in combination with non-NSAID analgesics. Its products under development includes BX1000, an intermediate-acting neuromuscular blocking agent (NMB) that is in phase II clinical trial; BX2000, an ultra- short acting NMBA, which is in phase I clinical trial; BX3000, an NMBA reversal agent; and Dex-IN, a proprietary intranasal formulation of dexmedetomidine. The company was incorporated in 2019 and is based in Malvern, Pennsylvania.
490 Lapp Road
Malvern, PA 19355
Malvern, PA 19355
CIK: 0001780097
ISIN: US07160F4046
CUSIP: 07160F206
